Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Labopin

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|January 10, 2024
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registryA Sadowska-Klasa, J M Zaucha, M Labopin, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Bone Marrow Transplantation|March 1, 1996
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experienceN Schmitz, A Bacigalupo, M Labopin, et al.
Bone Marrow Transplantation|July 24, 2008
Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach ProgrammeJ Wachowiak, M Labopin, M Miano, et al.
British Journal of Haematology|December 1, 1996
Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)N Schmitz, A Bacigalupo, M Labopin, et al.
Experimental Hematology|January 21, 2000
Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institutionN C Gorin, M Labopin, J P Laporte, et al.
Leukemia|June 16, 2012
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantationF Baron, M Labopin, D Niederwieser, et al.
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
Bone Marrow Transplantation|January 15, 2014
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationF Baron, M Labopin, D Blaise, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|January 10, 2024
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registryA Sadowska-Klasa, J M Zaucha, M Labopin, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Bone Marrow Transplantation|March 1, 1996
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experienceN Schmitz, A Bacigalupo, M Labopin, et al.
Bone Marrow Transplantation|July 24, 2008
Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach ProgrammeJ Wachowiak, M Labopin, M Miano, et al.
British Journal of Haematology|December 1, 1996
Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)N Schmitz, A Bacigalupo, M Labopin, et al.
Experimental Hematology|January 21, 2000
Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institutionN C Gorin, M Labopin, J P Laporte, et al.
Leukemia|June 16, 2012
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantationF Baron, M Labopin, D Niederwieser, et al.
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
Bone Marrow Transplantation|January 15, 2014
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationF Baron, M Labopin, D Blaise, et al.
Pageof 13